These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20080706)

  • 1. Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions.
    Scherer EM; Leaman DP; Zwick MB; McMichael AJ; Burton DR
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1529-34. PubMed ID: 20080706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.
    Xu H; Song L; Kim M; Holmes MA; Kraft Z; Sellhorn G; Reinherz EL; Stamatatos L; Strong RK
    J Virol; 2010 Jan; 84(2):1076-88. PubMed ID: 19906921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J; Wyatt RT
    PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.
    Brunel FM; Zwick MB; Cardoso RM; Nelson JD; Wilson IA; Burton DR; Dawson PE
    J Virol; 2006 Feb; 80(4):1680-7. PubMed ID: 16439525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF
    J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
    Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
    Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.
    Huarte N; Lorizate M; Maeso R; Kunert R; Arranz R; Valpuesta JM; Nieva JL
    J Virol; 2008 Sep; 82(18):8986-96. PubMed ID: 18596094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    Wibmer CK; Gorman J; Ozorowski G; Bhiman JN; Sheward DJ; Elliott DH; Rouelle J; Smira A; Joyce MG; Ndabambi N; Druz A; Asokan M; Burton DR; Connors M; Abdool Karim SS; Mascola JR; Robinson JE; Ward AB; Williamson C; Kwong PD; Morris L; Moore PL
    PLoS Pathog; 2017 Jan; 13(1):e1006074. PubMed ID: 28076415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies.
    Yang G; Holl TM; Liu Y; Li Y; Lu X; Nicely NI; Kepler TB; Alam SM; Liao HX; Cain DW; Spicer L; VandeBerg JL; Haynes BF; Kelsoe G
    J Exp Med; 2013 Feb; 210(2):241-56. PubMed ID: 23359068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.
    Klein JS; Gnanapragasam PN; Galimidi RP; Foglesong CP; West AP; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7385-90. PubMed ID: 19372381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization.
    Kim M; Sun ZY; Rand KD; Shi X; Song L; Cheng Y; Fahmy AF; Majumdar S; Ofek G; Yang Y; Kwong PD; Wang JH; Engen JR; Wagner G; Reinherz EL
    Nat Struct Mol Biol; 2011 Oct; 18(11):1235-43. PubMed ID: 22002224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
    Lai RP; Hock M; Radzimanowski J; Tonks P; Hulsik DL; Effantin G; Seilly DJ; Dreja H; Kliche A; Wagner R; Barnett SW; Tumba N; Morris L; LaBranche CC; Montefiori DC; Seaman MS; Heeney JL; Weissenhorn W
    J Biol Chem; 2014 Oct; 289(43):29912-26. PubMed ID: 25160627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
    Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
    J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.
    Ofek G; Zirkle B; Yang Y; Zhu Z; McKee K; Zhang B; Chuang GY; Georgiev IS; O'Dell S; Doria-Rose N; Mascola JR; Dimitrov DS; Kwong PD
    J Virol; 2014 Mar; 88(5):2426-41. PubMed ID: 24335316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
    Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.